Valuation StemRIM

Stocks

Market Closed - Japan Exchange 09:30:00 18/09/2026 +03			5-day change	1st Jan Change
177.00 ^JPY	+3.51%		-25.94%	-32.70%

09-09	StemRIM Reports Earnings Results for the Full Year Ended July 31, 2026	CI
07-22	Stemrim Announces Patent Registration in Mexico for Redasemtide as Therapeutic Agent for Cartilage Disorders	CI

Data adjusted to current consolidation scope

Fiscal Period: July	2020	2021	2022	2023	2024	2025
Market Cap ¹	46,285	39,013	49,873	56,361	27,624	19,759
Change	-	-15.71%	27.84%	13.01%	-50.99%	-28.47%
Enterprise Value (EV) ¹	35,618	28,847	40,996	46,144	19,214	12,765
Change	-	-19.01%	42.12%	12.56%	-58.36%	-33.56%
P/E	143x	-66.2x	-25.5x	344x	-13.6x	-10.2x
PBR	4.25x	3.65x	5.3x	5.44x	3.11x	2.7x
PEG	-	0x	-0x	-3x	0x	1.85x
Capitalization / Revenue	22x	27.9x	2,267x	24x	-	-
EV / Revenue	17x	20.6x	1,863x	19.6x	-	-
EV / EBITDA	84.2x	-52.4x	-21.2x	243x	-9.46x	-6.64x
EV / EBIT	85.6x	-48.6x	-20.7x	323x	-9.26x	-6.48x
EV / FCF	129x	-40.1x	-32.5x	104x	-11.6x	-11.9x
FCF Yield	0.77%	-2.49%	-3.08%	0.96%	-8.6%	-8.38%
Dividend per Share ²	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-
EPS ²	5.74	-10.02	-32.91	2.69	-32.98	-31.16
Distribution rate	-	-	-	-	-	-
Net sales ¹	2,100	1,400	22	2,350	-	-
EBITDA ¹	423	-550	-1,932	190	-2,032	-1,922
EBIT ¹	416	-593	-1,981	143	-2,076	-1,971
Net income ¹	347	-582	-1,948	168	-2,022	-1,929
Net Debt ¹	-10,667	-10,166	-8,877	-10,217	-8,410	-6,994
Reference price ²	820.00	663.00	840.00	926.00	449.00	318.00
Nbr of stocks (in thousands)	56,445	58,843	59,373	60,864	61,523	62,136
Announcement Date	10/29/20 A	10/28/21 A	10/27/22 A	10/26/23 A	10/31/24 A	10/21/25 A

¹JPY in Million²JPY

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
STEMRIM	-	-	-	-	68.79M
REGENERON PHARMACEUTICALS, INC.	18.28x	4.23x	9.95x	0.49%	78.83B
CSL LIMITED	20.79x	4.42x	13.68x	2.38%	60.48B
MODERNA, INC.	-18.86x	28.3x	-18.37x	-.--%	63.11B
SAMSUNG BIOLOGICS CO.,LTD.	34.01x	11.57x	22.18x	-.--%	46.75B
UCB	20.84x	4.61x	13.13x	0.7%	45.66B
BIOGEN INC.	35.73x	3.57x	13.39x	-.--%	32.37B
INCYTE CORPORATION	56.95x	3.64x	28.22x	-.--%	25.87B
INNOVENT BIOLOGICS, INC.	63.18x	6.76x	40.46x	-.--%	21.33B
SWEDISH ORPHAN BIOVITRUM AB	23.37x	5.01x	13.06x	-.--%	15.8B
Average	28.25x	8.01x	15.08x	0.4%	39.03B
Weighted average by Cap.	21.52x	9.15x	11.08x	0.55%